Weiss Multi-Strategy Advisers’s Achillion Pharmaceuticals ACHN Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-20,000	Closed	-$245K	–	555
2014 Q4	$245K	Buy	+20,000	New	+$244K	0.01%	373

Weiss Multi-Strategy Advisers's ACHN Position: Q1 2020 in Review

Weiss Multi-Strategy Advisers sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 2,848,261 shares — an estimated $17.2M sold.

Weiss Multi-Strategy Advisers first reported a position in ACHN in Q2 2013 and held it in 8 quarters. The position peaked at $17.2M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Weiss Multi-Strategy Advisers reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 2,848,261 Achillion Pharmaceuticals shares in Q1 2020, an estimated $17.2M.
Weiss Multi-Strategy Advisers first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 8 quarters.
Weiss Multi-Strategy Advisers's Achillion Pharmaceuticals position peaked at $17.2M in Q4 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2020, filed 15 May 2020.